dr. nicholas vogelzang discusses sequencing abiraterone and enzalutamide
Published 11 years ago • 802 plays • Length 1:53
Download video MP4
Download video MP3
Similar videos
-
2:31
dr. nicholas vogelzang discusses latest advances in prostate cancer
-
1:12
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
3:07
dr. vogelzang discusses the addition of chemotherapy to adt in men with prostate cancer
-
0:55
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
1:49
dr. nicholas vogelzang discusses radium-223 in prostate cancer
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
21:55
dr christian frezza - mitochondrial dysfunction in cancer
-
5:19
xtandi patient stories
-
2:55
dr. nicholas vogelzang discusses psma adc in prostate cancer
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
1:21
dr. shore on the enzalutamide mechanism of action
-
1:34
dr. vogelzang discusses prospect trial for prostate cancer
-
1:19
dr. nicholas vogelzang on first-line axitinib versus sorafenib in mrcc
-
0:59
nicholas j. vogelzang, md, fasco, facp, on identifying the best patients for zytiga versus xtandi
-
0:59
dr. crawford on abiraterone versus enzalutamide in prostate cancer
-
0:52
dr. vogelzang discusses the prostate health cocktail
-
1:41
nicholas j. vogelzang, md, on where chemotherapy fits into treatment for prostate cancer
-
5:01
2013 oncprac summit: nicholas vogelzang on how he treats metastic prostate cancer
-
5:37
oral hormonal agents for metastatc castration-resistant prostate cancer
-
1:53
nicholas vogelzang, md, explains how cabazitaxel should be used in various lines of treatment in mpc
-
1:34
dr. chi on abiraterone versus enzalutamide for metastatic castration-resistant prostate cancer
Clip.africa.com - Privacy-policy